This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Closed Joint Stock Company “Biocad”. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Solikamsk Permsky kray, RU (2019)
- Solikamsk, RU (2019)
Company Filing History:
Years Active: 2019
Title: Yulia Sergeevna Chernyh: Innovator in Monoclonal Antibodies
Introduction
Yulia Sergeevna Chernyh is a prominent inventor based in Solikamsk, Russia. She has made significant contributions to the field of medicine, particularly in the development of monoclonal antibodies. With a total of 2 patents to her name, her work focuses on innovative treatments for autoimmune and inflammatory disorders.
Latest Patents
Chernyh's latest patents include groundbreaking inventions related to Anti-IL-17 antibodies. The first patent describes monoclonal antibodies that target human IL-17, specifically IL-17A. These antibodies are designed to bind with high affinity to an IL-17 epitope and can be chimeric, humanized, or human antibodies. They hold potential as medicinal agents for treating various disorders, including autoimmune diseases. The second patent details monoclonal IgG-type antibodies that incorporate variable domains from a VHH-derivative and a light chain. These antibodies exhibit increased affinity and improved aggregation stability, making them valuable in therapeutic applications.
Career Highlights
Chernyh is associated with Closed Joint Stock Company “Biocad,” where she continues her research and development efforts. Her work has positioned her as a key figure in the advancement of antibody therapies.
Collaborations
Chernyh collaborates with notable colleagues, including Stanislav Rudolfovich Evdokimov and Olga Vladimirovna Goncharova. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Yulia Sergeevna Chernyh is a trailblazer in the field of monoclonal antibodies, with her inventions paving the way for new treatments in medicine. Her contributions are vital in addressing complex health challenges, and her ongoing work promises to yield further advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile